Increased prevalence of polycystic ovary syndrome in premenopausal women with nonalcoholic fatty liver disease

European Journal of Endocrinology

Volumn 173, Issue 6, 2015, Pages 739-747

  Vassilatou, E ^a   Vassiliadi, D A ^a   Salambasis, K ^b   Lazaridou, H ^b   Koutsomitopoulos, N ^a   Kelekis, N ^b   Kassanos, D ^b   Hadjidakis, D ^a,b   Dimitriadis, G ^b  

^a NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA GLUTAMYLTRANSFERASE; INSULIN; SEX HORMONE BINDING GLOBULIN; TRIACYLGLYCEROL; URIC ACID;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; CLINICAL ASSESSMENT; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; ECHOGRAPHY; FEMALE; FREE ANDROGEN INDEX; GLUCOSE METABOLISM; HOMEOSTASIS MODEL ASSESSMENT OF INSULIN RESISTANCE; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; METABOLIC SYNDROME X; NONALCOHOLIC FATTY LIVER; OBESITY; OBSERVATIONAL STUDY; OVARY POLYCYSTIC DISEASE; PREMENOPAUSE; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCORING SYSTEM; WAIST HIP RATIO; ADOLESCENT; COHORT ANALYSIS; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; POLYCYSTIC OVARY SYNDROME; YOUNG ADULT;

ADOLESCENT; ADULT; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; POLYCYSTIC OVARY SYNDROME; PREMENOPAUSE; PREVALENCE; PROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84947938206     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-15-0567     Document Type: Article

References (36)

1. Angulo P. Nonalcoholic fatty liver disease. New England Journal of Medicine 2002 346 1221-1231. (doi:10.1056/NEJMra011775)
2. Nomura H, Kashiwagi S, Hayashi J, Kajiyama W, Tani S & Goto M. Prevalence of fatty liver in a general population of Okinawa, Japan. Japanese Journal of Medicine 1988 27 142-149. (doi:10.2169/internalmedicine1962.27.142)
3. Szczepaniak LS, Nurenberg P, Leonard D, Browning JD, Reingold JS, Grundy S, Hobbs HH & Dobbins RL. Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population. American Journal of Physiology. Endocrinology and Metabolism 2005 288 E462-E468. (doi:10.1152/ajpendo.00064.2004)
4. Utzschneider KM & Kahn SE. Review: the role of insulin resistance in in nonalcoholic fatty liver disease. Journal of Clinical Endocrinology and Metabolism 2006 91 4753-4761. (doi:10.1210/jc.2006-0587)
5. Hocking S, Samocha-Bonet D, Milner K-L, Greenfield JR & Chisholm DJ. Adiposity and insulin resistance in humans: the role of the different tissue and cellular lipid depots. Endocrine Reviews 2013 34 463-500. (doi:10.1210/er.2012-1041)
6. Bedogni G, Miglioli L, Masutti F, Tiribelli C, Marchesini G & Bellentani S. Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study. Hepatology 2005 42 44-52. (doi:10.1002/hep.20734)
7. Leite NC, Salles GF, Araujo AL, Villela-Nogueira CA & Cardoso CR. Prevalence and associated factors of non-alcoholic fatty liver disease in patients with type-2 diabetes mellitus. Liver International 2009 29 113-119. (doi:10.1111/j.1478-3231.2008.01718.x)
8. Marchesini G, Brizi M, Bianchi G, Tomassetti S, Bugianesi E, Lenzi M, Mc Cullough AJ, Natale S, Forlani G & Melchionda N. Nonalcoholic fatty liver disease: a feature of metabolic syndrome. Diabetes 2001 50 1844-1850. (doi:10.2337/diabetes.50.8.1844)
9. Clark JM. The epidemiology of nonalcoholic fatty liver disease in adults. Journal of Clinical Gastroenterology 2006 40 S5-S10.
10. Pan J-J & Fallon MB. Gender and racial differences in nonalcoholic fatty liver disease. World Journal of Hepatology 2014 6 274-283. (doi:10.4254/wjh.v6.i5.274)
11. Hamaguchi M, Kojima T, Ohbora A, Takeda N, Fukui M & Kato T. Aging is a risk factor of nonalcoholic fatty liver disease in premenopausal women. World Journal of Gastroenterology 2012 18 237-243. (doi:10.3748/wjg.v18.i3.237)
12. Gutierrez-Grobe Y, Ponciano-Rodríguez G, Ramos MH, Uribe M & Méndez-Sánchez N. Prevalence of nonalcoholic fatty liver disease in premenopausal, posmenopausal and polycystic ovary syndrome women. The role of estrogens. Annals of Hepatology 2010 9 402-409.
13. Vassilatou E. Nonalcoholic fatty liver disease and polycystic ovary syndrome. World Journal of Gastroenterology 2014 20 8351-8363. (doi:10.3748/wjg.v20.i26.8351)
14. March WA, Moore VM, Willson KJ, Phillips DI, Norman RJ & Davies MJ. The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Human Reproduction 2010 25 544-551. (doi:10.1093/humrep/dep399)
15. Diamanti-Kandarakis E & Dunaif A. Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications. Endocrine Reviews 2012 33 981-1030. (doi:10.1210/er.2011-1034)
16. Randeva HS, Tan BK, Weickert MO, Lois K, Nestler JE, Sattar N & Lehnert H. Cardiometabolic aspects of the polycystic ovary syndrome. Endocrine Reviews 2012 33 812-841. (doi:10.1210/er.2012-1003)
17. Schwimmer JB, Khorram O, Chiu V & Schwimmer WB. Abnormal aminotransferase activity in women with polycystic ovary syndrome. Fertility and Sterility 2005 83 494-497. (doi:10.1016/j. fertnstert.2004.08.020)
18. Cerda C, Pérez-Ayuso RM, Riquelme A, Soza A, Villaseca P, Sir-Petermann T, Espinoza M, Pizarro M, Solis N, Miquel JF et al. Nonalcoholic fatty liver disease in women with polycystic ovary syndrome. Journal of Hepatology 2007 47 412-417. (doi:10.1016/j.jhep.2007.04.012)
19. Lerchbaum E, Gruber HJ, Schwetz V, Giuliani A, Möller R, Pieber TR & Obermayer-Pietsch B. Fatty liver index in polycystic ovary syndrome. European Journal of Endocrinology 2011 165 935-943. (doi:10.1530/EJE-11-0614)
20. Vassilatou E, Lafoyianni S, Vryonidou A, Ioannidis D, Kosma L, Katsoulis K, Papavassiliou E & Tzavara I. Increased androgen bioavail-ability is associated with non-alcoholic fatty liver disease in women with polycystic ovary syndrome. Human Reproduction 2010 25 212-220. (doi:10.1093/humrep/dep380)
21. Chen MJ, Chiu HM, Chen CL, Yang WS, Yang YS & Ho HN. Hyperandrogenemia is independently associated with elevated alanine aminotransferase activity in young women with polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism 2010 95 3332-3341. (doi:10.1210/jc.2009-2698)
22. Jones H, Sprung VS, Pugh CJ, Daousi C, Irwin A, Aziz N, Adams VL, Thomas EL, Bell JD, Kemp GJ et al. Polycystic ovary syndrome with hyperandrogenism is characterized by an increased risk of hepatic steatosis compared to nonhyperandrogenic PCOS phenotypes and healthy controls, independent of obesity and insulin resistance. Journal of Clinical Endocrinology and Metabolism 2012 97 3709-3716. (doi:10.1210/jc.2012-1382)
23. Carmina E. Need for liver evaluation in polycystic ovary syndrome. Journal of Hepatology 2007 47 313-315. (doi:10.1016/j.jhep.2007.06.009)
24. Brzozowska MM, Ostapowicz G & Weltman MD. An association between non-alcoholic fatty liver disease and polycystic ovarian syndrome. Journal of Gastroenterology and Hepatology 2009 24 243-247. (doi:10.1111/j.1440-1746.2008.05740.x)
25. Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Human Reproduction 2004 19 41-47. (doi:10.1093/humrep/deh098)
26. Hatch R, Rosenfield RL, Kim MH & Tredway D. Hirsutism-implications, etiology, and management. American Journal of Obstetrics and Gynecology 1981 140 815-830.
27. JNC VI. The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Archives of Internal Medicine 1997 157 2413-2446. (doi:10.1001/archinte.1997.00440420033005)
28. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2004 27 (Suppl 1) S5-S10.
29. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002 106 3143-3421.
30. Gutt M, Davis CL, Spitzer SB, Llabre MM, Kumar M, Czarnecki EM, Schneiderman N, Skyler JS & Marks JB. Validation of the insulin sensitivity index ISI (0,120): comparison with other measures. Diabetes Research and Clinical Practice 2000 47 177-184. (doi:10.1016/S0168-8227(99)00116-3)
31. Saadeh S, Younossi ZM, Remer EM, Gramlich T, Ong JP, Hurley M, Mullen KD, Cooper JN & Sheridan MJ. The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology 2002 123 745-750. (doi:10.1053/gast.2002.35354)
32. Balen AH, Laven JS, Tan SL & Dewailly D. Ultrasound assessment of the polycystic ovary: international consensus definitions. Human Reproduction Update 2003 9 505-514. (doi:10.1093/humupd/dmg044)
33. Alvarez-Blasco F, Botella-Carretero JI, San Millan JL & Escobar-Morreale HF. Prevalence and characteristics of the polycystic ovary syndrome in overweight and obese women. Archives of Internal Medicine 2006 166 2081-2086. (doi:10.1001/archinte.166.19.2081)
34. Flechtner-Mors M, Schick A, Oeztuerk S, Haenle MM, Wilhelm M, Koenig W, Imhof A, Boehm BO, Graeter T, Mason RA et al. Associations of fatty liver disease and other factors affecting serum SHBG concentrations: a population based study on 1657 subjects. Hormone and Metabolic Research 2014 46 287-293.
35. Polyzos SA, Kountouras J, Tsatsoulis A, Zafeiriadou E, Katsiki E, Patsiaoura K, Zavos C, Anastasiadou VV & Slavakis A. Sex steroids and sex hormone-binding globulin in postmenopausal women with nonalcoholic fatty liver disease. Hormones (Athens) 2013 12 405-416.
36. Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt EM, Cusi K, Charlton M & Sanyal AJ. The diagnosis and management of nonalcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology. Gastroenterology 2012 142 1592-1609. (doi:10.1053/j.gastro.2012.04.001)